Cargando…
STAT3 regulated ARF expression suppresses prostate cancer metastasis
Prostate cancer (PCa) is the most prevalent cancer in men. Hyperactive STAT3 is thought to be oncogenic in PCa. However, targeting of the IL-6/STAT3 axis in PCa patients has failed to provide therapeutic benefit. Here we show that genetic inactivation of Stat3 or IL-6 signalling in a Pten-deficient...
Autores principales: | Pencik, Jan, Schlederer, Michaela, Gruber, Wolfgang, Unger, Christine, Walker, Steven M., Chalaris, Athena, Marié, Isabelle J., Hassler, Melanie R., Javaheri, Tahereh, Aksoy, Osman, Blayney, Jaine K., Prutsch, Nicole, Skucha, Anna, Herac, Merima, Krämer, Oliver H., Mazal, Peter, Grebien, Florian, Egger, Gerda, Poli, Valeria, Mikulits, Wolfgang, Eferl, Robert, Esterbauer, Harald, Kennedy, Richard, Fend, Falko, Scharpf, Marcus, Braun, Martin, Perner, Sven, Levy, David E., Malcolm, Tim, Turner, Suzanne D., Haitel, Andrea, Susani, Martin, Moazzami, Ali, Rose-John, Stefan, Aberger, Fritz, Merkel, Olaf, Moriggl, Richard, Culig, Zoran, Dolznig, Helmut, Kenner, Lukas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Pub. Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525303/ https://www.ncbi.nlm.nih.gov/pubmed/26198641 http://dx.doi.org/10.1038/ncomms8736 |
Ejemplares similares
-
Erratum: STAT3 regulated ARF expression suppresses prostate cancer metastasis
por: Pencik, Jan, et al.
Publicado: (2015) -
Thyroid and androgen receptor signaling are antagonized by μ‐Crystallin in prostate cancer
por: Aksoy, Osman, et al.
Publicado: (2020) -
Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation
por: Javaheri, Tahereh, et al.
Publicado: (2016) -
Correction: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation
por: Javaheri, Tahereh, et al.
Publicado: (2018) -
Retraction Note: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation
por: Javaheri, Tahereh, et al.
Publicado: (2019)